Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Tango Therapeutics
Biotech
Seagen finally finds new CEO—Chutes & Ladders
Seagen finally finds new CEO; Biogen taps Sanofi vet to lead; Former Sage Therapeutics CEO to helm new biotech incubator.
Gabrielle Masson
,
Max Bayer
Nov 11, 2022 9:30am
Tango finds a quick step to Wall Street via $353M SPAC deal
Apr 14, 2021 10:39am
It still takes 2 to Tango as Gilead triples targets in I-O deal
Aug 17, 2020 10:15pm
Tango Therapeutics banks $60M to push synthetic lethality drug
Apr 9, 2020 8:00am
Third Rock, Tango decamp to Boston's Fenway neighborhood
Feb 26, 2020 10:54am
Gilead pays $50M to team up with synthetic lethality startup
Oct 31, 2018 8:30am
